/Passle/67292836ee4aa642c0980b65/SearchServiceImages/2025-11-13-02-39-50-388-691544f6d27e4830197c7465.jpg)
The U.S. House of Representatives voted 222 to 209 to pass the Senate amendment to the continuing resolution, effectively ending the...
Reed Smith LLP
The Department of Health and Human Services, Office of Inspector General (OIG) recently issued a favorable advisory opinion (Advisory...
On May 5, the Trump Administration issued a pair of executive orders that could signal big changes for the drug industry and health...
This post was co-authored by Megan E. McWaters, a Reed Smith summer associate. In a unanimous decision, the U.S. Supreme Court overturned...
As Reed Smith has previously covered, an issue before the Supreme Court that could be decided this week could bring a seismic shift in...
The U.S. Supreme Court heard arguments yesterday in the two consolidated cases challenging the U.S. Food and Drug Administration (FDA)...
UPDATE: Late in the evening of September 28, the House defeated H.R. 4368 by a vote of 191-237, with 27 Republicans voting against the...
On April 7, 2023, only minutes apart, two federal district courts issued rulings on cases challenging the Food and Drug Administration’s...
On February 28, 2023, the Department of Health and Human Services’ Office of Inspector General (“OIG”) issued a favorable advisory...
On May 10, 2022, FDA published draft guidance entitled, “Benefit-Risk Considerations for Product Quality Assessments”, which describes...
The House Energy and Commerce Committee seems poised to make substantial changes to the Food and Drug Administration’s (“FDA’s”)...
On October 5, 2021, the U.S. Food and Drug Administration (“FDA”) published a final rule to establish requirements for the medical device...
On July 1, 2021, the Department of Justice (DOJ) released a memorandum signed by Attorney General Merrick Garland regarding the issuance...
On August 2, 2021, the U.S. Food and Drug Administration (“FDA”) published a final rule amending existing regulations (21 C.F.R. §...
The Food and Drug Administration (“FDA”) and the Federal Trade Commission (“FTC”) have been fighting fraudulent and deceptive advertising...
On August 31, 2020, the Food and Drug Administration (FDA) issued draft guidance regarding principles for selecting, developing,...